| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |